The clinical presentation of generalized anxiety in primary-care settings: Practical concepts of classification and management

Journal of Clinical Psychiatry

Volumn 58, Issue 11 SUPPL., 1997, Pages 4-10

  Rickels, Karl ^a   Schweizer, Edward ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPRAZOLAM; ANXIOLYTIC AGENT; BENZODIAZEPINE; BUSPIRONE; CLORAZEPATE; CLORAZEPATE DIPOTASSIUM; IMIPRAMINE; LORAZEPAM; SEROTONIN 1A AGONIST; TRICYCLIC ANTIDEPRESSANT AGENT;

ANXIETY NEUROSIS; ARTICLE; CLINICAL TRIAL; COGNITIVE THERAPY; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DISEASE CLASSIFICATION; DOUBLE BLIND PROCEDURE; HUMAN; MENTAL DISEASE; PATIENT COUNSELING; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PSYCHIATRIC DIAGNOSIS; PSYCHOPHARMACOTHERAPY; PSYCHOTHERAPY; TREATMENT OUTCOME;

ANTI-ANXIETY AGENTS; ANXIETY DISORDERS; CHRONIC DISEASE; COMBINED MODALITY THERAPY; DRUG ADMINISTRATION SCHEDULE; FAMILY PRACTICE; HUMANS; PRIMARY HEALTH CARE; PSYCHOTHERAPY; RECURRENCE; TREATMENT OUTCOME;

EID: 0030726525     PISSN: 01606689     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (31)

1. Blazer DG, Hughes D, George LK, et al. Generalized anxiety disorder. In: Robins LN, Regier DA, eds. The Psychiatric Disorders in America: The Epidemiologic Catchment Area Study. New York, NY: The Free Press; 1991:180-203
2. Wittchen H-U, Zhao S, Kessler RC, et al. DSM-IIIR generalized anxiety disorder in the national comorbidity survey. Arch Gen Psychiatry 1994;51: 355-364
3. Massion AO, Warshaw MG, Keller MB. Quality of life and psychiatric morbidity in panic disorder and generalized anxiety disorder. Am J Psychiatry 1993;150:600-607
4. Fifer SK, Mathias SD, Patrick DL, et al. Untreated anxiety among adult primary care patients in a health maintenance organization. Arch Gen Psychiatry 1994;51:740-750
5. Katon W, Von Korff M, Lin E, et al. Distressed high utilizers of medical care, DSM-III-R diagnoses and treatment needs. Gen Hosp Psychiatry 1990;12:355-362
6. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition. Washington, DC: American Psychiatric Association; 1994
7. Rickels K, Wiseman K, Norstad N, et al. Buspirone and diazepam in anxiety: a controlled study. J Clin Psychiatry 1982;43:81-86
8. Rickels K, Downing R, Schweizer E, et al. Antidepressants for the treatment of generalized anxiety disorder: a placebo-controlled comparison of imipramine, trazodone and diazepam. Arch Gen Psychiatry 1993;50: 884-895
9. NIH Consensus Conference. Drugs and insomnia. JAMA 1984;251: 2410-2414
10. Angst J, Hochstrasser B. Recurrent brief depression: the Zurich study. J Clin Psychiatry 1994;55(4, suppl):3-9
11. Keller MB, Lavori PW, Endicott J, et al. Double depression: two year follow-up. Am J Psychiatry 1983;140:689-694
12. Rickels K, Schweizer E. Maintenance treatment studies in anxiety disorders: some methodological notes. Psychopharmacol Bull 1995;31:115-123
13. Rickels K, Fox IL, Greenblatt DJ, et al. Clorazepate and lorazepam: clinical-improvement and rebound anxiety. Am J Psychiatry 1988;145: 312-317
14. Fontaine R. Chouinard G, Annable A. Rebound anxiety in anxious patients after abrupt withdrawal of benzodiazepine treatment. Am J Psychiatry 1984;141:848-852
15. Winokur A, Rickels K, Greenblatt DJ, et al. Withdrawal reaction from long-term low-dosage administration of diazepam. Arch Gen Psychiatry 1980;37:101-105
16. Rickels K, Schweizer E, Case WG, et al. Long-term therapeutic use of benzodiazepines, I: effects of abrupt discontinuation. Arch Gen Psychiatry 1990;47:899-907
17. Schweizer E, Rickels K, Case WG, et al. Long-term therapeutic use of benzodiazepines, II: effects of gradual taper. Arch Gen Psychiatry 1990;47: 908-915
18. Lucki I, Rickels K, Geller AM. Chronic use of benzodiazepines and psychomotor and cognitive test performance. Psychopharmacology 1986;88: 426-433
19. Rickels K. Alprazolam in the management of anxiety. In: Lader MH, Davies HC, eds. Drug Treatment of Neurotic Disorders - Focus on Alprazolam. Edinburgh, Scotland: Churchill Livingstone; 1985:84-93
20. Rickels K, Case WG, Downing R, et al. Long-term diazepam therapy and clinical outcome. JAMA 1983;250:767-771
21. Rickels K, Schweizer E, Csanalosi I, et al. Long-term treatment of anxiety and risk of withdrawal: prospective comparison of clorazepate and buspirone. Arch Gen Psychiatry 1988;45:444-450
22. Rickels K, Schweizer E, Weiss S, et al. Maintenance drug treatment for panic disorder, II: short and long-term outcome after drug taper. Arch Gen Psychiatry 1993;50:61-68
23. Rickels K, Case WG, Downing RW, et al. One-year follow-up of anxious patients treated with diazepam. J Clin Psychopharmacol 1986;6:32-36
24. Rickels K, Schweizer E. The clinical course and long-term management of generalized anxiety disorder. J Clin Psychopharmacol 1990;10:101S-110S
25. Scheibe G. Four-year follow-up in 40 outpatients with anxiety disorders: buspirone versus lorazepam. Eur J Psychiatry 1996;10:25-34
26. Rickels K, ed. Non-Specific Factors in Drug Therapy. Springfield, Ill: Charles C. Thomas; 1968
27. Fisher S, Cole JO, Rickels K, et al. Drug-set interaction: the effect of expectations on drug response in outpatients. In: Bradley PB, Fluegel F, Hoch P, eds. Neuropsychopharmacology. Amsterdam, The Netherlands: Elsevier; 1964;3:149-156
28. Lipman RS, Park LC, Rickels K. Paradoxical influence of a therapeutic side-effect interpretation. Arch Gen Psychiatry 1966;15:462-474
29. Uhlenhuth EH, Rickels K, Fisher S, et al. Drug, doctor's verbal attitude and clinic setting in the symptomatic response to pharmacotherapy. Psychopharmacologia 1966;9:392-418
30. Rickels K. Use of anti-anxiety agents in anxious outpatients. Psychopharmacology 1978;58:1-17
31. Stuart MR, Lieberman JA. The Fifteen Minute Hour: Applied Psychotherapy for the Primary Care Physician. 2nd ed. Westport, Conn: Praeger Publications; 1993